Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Clinical trial NCT02341560 · TERMINATED
Trial details
- NCT number
- NCT02341560
- Sponsor
- Quark Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-24
- Primary completion
- 2019-07-01
- Enrollment
- 732
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.